Detalles de la búsqueda
1.
Incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high responders after gonadotropin-releasing hormone (GnRH) agonist trigger in "freeze-all" approach.
Gynecol Endocrinol
; 39(1): 2205952, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37156263
2.
Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
Hum Reprod
; 34(12): 2495-2512, 2019 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31820802
3.
Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.
Hum Reprod
; 26(12): 3413-23, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21954280
4.
A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol.
Hum Reprod
; 24(12): 3063-72, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19684043
5.
Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone.
Endocrinology
; 129(5): 2623-30, 1991 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-1935792
6.
Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
J Clin Endocrinol Metab
; 89(5): 2062-70, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15126522
7.
Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility.
J Clin Endocrinol Metab
; 89(12): 6297-304, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15579793
8.
Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency.
J Clin Endocrinol Metab
; 74(6): 1471-3, 1992 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-1592896
9.
Follitropin-beta administered by pen device has superior local tolerance compared with follitropin-alpha administered by conventional syringe.
Reprod Biomed Online
; 3(3): 185-189, 2001.
Artículo
en Inglés
| MEDLINE | ID: mdl-12513852
10.
A dose proportionality study of subcutaneously and intramuscularly administered recombinant human follicle-stimulating hormone (Follistim*/Puregon) in healthy female volunteers.
Fertil Steril
; 73(6): 1187-93, 2000 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-10856481
11.
Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism.
Fertil Steril
; 59(4): 738-42, 1993 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-8458489
12.
Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects.
Fertil Steril
; 61(1): 62-9, 1994 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-8293846
13.
Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins.
Fertil Steril
; 68(1): 138-42, 1997 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-9207599
14.
Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism.
Fertil Steril
; 65(2): 406-10, 1996 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-8566271
15.
Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part I. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers.
Fertil Steril
; 72(6): 1001-5, 1999 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-10593371
16.
Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers.
Fertil Steril
; 72(6): 1006-12, 1999 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-10593372
17.
Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteers.
Fertil Steril
; 59(1): 108-14, 1993 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-8419196
18.
Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).
Fertil Steril
; 75(4): 688-93, 2001 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11287020
19.
Sister chromatid exchanges in calves with hereditary zinc deficiency (lethal trait A 46).
Vet Q
; 10(4): 230-3, 1988 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-3218064
20.
The use of recombinant FSH for ovulation induction.
Ann Endocrinol (Paris)
; 55(2): 79-83, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-7802431